Novel potential neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons
Authors:
- Mati FridkinMFMati Fridkin
- 1 November 2005
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 70 (11) , 1642-1652
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Iron, brain ageing and neurodegenerative disordersNature Reviews Neuroscience, 2004
- Modular and Tunable Chemosensor Scaffold for Divalent ZincJournal of the American Chemical Society, 2003
- Antioxidant Therapy in Acute Central Nervous System Injury: Current StatePharmacological Reviews, 2002
- Iron accumulation in the substantia nigra of autosomal recessive juvenile parkinsonism (ARJP)Parkinsonism & Related Disorders, 2001
- Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrierNeuropharmacology, 2001
- Drug treatment of Parkinson’s diseaseBiochemical Pharmacology, 2000
- Prospects for new restorative and neuroprotective treatments in Parkinson's diseaseNature, 1999
- The Role of Iron in NeurodegenerationDrugs & Aging, 1999
- Stereoselective Synthesis of Fluorescent α-Amino Acids Containing Oxine (8-Hydroxyquinoline) and Their Peptide Incorporation in Chemosensors for Divalent ZincThe Journal of Organic Chemistry, 1998
- Redox Signaling and the Emerging Therapeutic Potential of Thiol AntioxidantsBiochemical Pharmacology, 1998